Next Article in Journal
Testudines as Sentinels for Monitoring the Dissemination of Antibiotic Resistance in Marine Environments: An Integrative Review
Next Article in Special Issue
RND Efflux Systems Contribute to Resistance and Virulence of Aliarcobacter butzleri
Previous Article in Journal
Salmonella Characterization in Poultry Eggs Sold in Farms and Markets in Relation to Handling and Biosecurity Practices in Ogun State, Nigeria
Previous Article in Special Issue
Exploring the Contribution of the AcrB Homolog MdtF to Drug Resistance and Dye Efflux in a Multidrug Resistant E. coli Isolate
Review

Ever-Adapting RND Efflux Pumps in Gram-Negative Multidrug-Resistant Pathogens: A Race against Time

by 1,* and 1,2,*
1
SANKEN (The Institute of Scientific and Industrial Research), Osaka University, Ibaraki, Osaka 567-0047, Japan
2
Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan
*
Authors to whom correspondence should be addressed.
Academic Editors: Henrietta Venter, Isabelle Broutin, Attilio V. Vargiu and Gilles Phan
Received: 27 May 2021 / Revised: 11 June 2021 / Accepted: 14 June 2021 / Published: 25 June 2021
The rise in multidrug resistance (MDR) is one of the greatest threats to human health worldwide. MDR in bacterial pathogens is a major challenge in healthcare, as bacterial infections are becoming untreatable by commercially available antibiotics. One of the main causes of MDR is the over-expression of intrinsic and acquired multidrug efflux pumps, belonging to the resistance-nodulation-division (RND) superfamily, which can efflux a wide range of structurally different antibiotics. Besides over-expression, however, recent amino acid substitutions within the pumps themselves—causing an increased drug efflux efficiency—are causing additional worry. In this review, we take a closer look at clinically, environmentally and laboratory-evolved Gram-negative bacterial strains and their decreased drug sensitivity as a result of mutations directly in the RND-type pumps themselves (from Escherichia coli, Salmonella enterica, Neisseria gonorrhoeae, Pseudomonas aeruginosa, Acinetobacter baumannii and Legionella pneumophila). We also focus on the evolution of the efflux pumps by comparing hundreds of efflux pumps to determine where conservation is concentrated and where differences in amino acids can shed light on the broad and even broadening drug recognition. Knowledge of conservation, as well as of novel gain-of-function efflux pump mutations, is essential for the development of novel antibiotics and efflux pump inhibitors. View Full-Text
Keywords: pathogens; multidrug resistance; RND; evolution; efflux pump; adaptation pathogens; multidrug resistance; RND; evolution; efflux pump; adaptation
Show Figures

Figure 1

MDPI and ACS Style

Zwama, M.; Nishino, K. Ever-Adapting RND Efflux Pumps in Gram-Negative Multidrug-Resistant Pathogens: A Race against Time. Antibiotics 2021, 10, 774. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics10070774

AMA Style

Zwama M, Nishino K. Ever-Adapting RND Efflux Pumps in Gram-Negative Multidrug-Resistant Pathogens: A Race against Time. Antibiotics. 2021; 10(7):774. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics10070774

Chicago/Turabian Style

Zwama, Martijn, and Kunihiko Nishino. 2021. "Ever-Adapting RND Efflux Pumps in Gram-Negative Multidrug-Resistant Pathogens: A Race against Time" Antibiotics 10, no. 7: 774. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics10070774

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop